CPD-1224 |
| Catalog No.GC68896 |
CPD-1224 is an orally effective ALK inhibitor and a derivative of the cereblon-coupled ligand ALK inhibitor. CPD-1224 targets the oncogenic fusion protein EML4-ALK and degrades both ALK and mutant variants L1196M/G1202R.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2891620-68-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for CPD-1224
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for CPD-1224
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *